Jason J. Luke, MD, FACP | Authors

Jason Luke, MD, Discusses Advancement of Immunotherapy For Metastatic Disease at 2021 ESMO

September 22, 2021

CancerNetwork® sat down with Jason Luke, MD, at the 2021 European Society for Medical Oncology Congress to talk about the latest developments in the use of immunotherapy for metastatic disease.

Jason Luke, MD, FACP, on BRAF Mutations, Melanocytes and Melanoma Treatments

November 12, 2020

CancerNetwork spoke with Jason Luke, MD, FACP, at the SMR Conference regarding the latest updates on melanoma.

Have We Won the Race in the Treatment of Advanced Melanoma-Or Are We Just Learning to Walk?

February 15, 2015

The unprecedented improvements in melanoma therapeutics over a short period of time have been nothing short of extraordinary. It may be that we are now on a road to cure, but surely the destination is not yet in sight.